AU2736101A - Transporters and ion channels - Google Patents
Transporters and ion channelsInfo
- Publication number
- AU2736101A AU2736101A AU27361/01A AU2736101A AU2736101A AU 2736101 A AU2736101 A AU 2736101A AU 27361/01 A AU27361/01 A AU 27361/01A AU 2736101 A AU2736101 A AU 2736101A AU 2736101 A AU2736101 A AU 2736101A
- Authority
- AU
- Australia
- Prior art keywords
- transporters
- ion channels
- channels
- ion
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 102000004310 Ion Channels Human genes 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/16—Emollients or protectives, e.g. against radiation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/12—Ophthalmic agents for cataracts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/08—Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Diabetes (AREA)
- Physical Education & Sports Medicine (AREA)
- Hematology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Pulmonology (AREA)
- Psychiatry (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Ophthalmology & Optometry (AREA)
- Virology (AREA)
- Obesity (AREA)
- Immunology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Molecular Biology (AREA)
- Urology & Nephrology (AREA)
- Endocrinology (AREA)
- Toxicology (AREA)
- Psychology (AREA)
Applications Claiming Priority (13)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US17200099P | 1999-12-23 | 1999-12-23 | |
US60172000 | 1999-12-23 | ||
US17608300P | 2000-01-14 | 2000-01-14 | |
US60176083 | 2000-01-14 | ||
US17733200P | 2000-01-21 | 2000-01-21 | |
US60177332 | 2000-01-21 | ||
US17857200P | 2000-01-28 | 2000-01-28 | |
US60178572 | 2000-01-28 | ||
US17975800P | 2000-02-02 | 2000-02-02 | |
US60179758 | 2000-02-02 | ||
US18162500P | 2000-02-10 | 2000-02-10 | |
US60181625 | 2000-02-10 | ||
PCT/US2000/035095 WO2001046258A2 (en) | 1999-12-23 | 2000-12-20 | Transporters and ion channels |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2736101A true AU2736101A (en) | 2001-07-03 |
Family
ID=27558609
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU27361/01A Abandoned AU2736101A (en) | 1999-12-23 | 2000-12-22 | Transporters and ion channels |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP1257578A2 (en) |
JP (1) | JP2004500814A (en) |
AU (1) | AU2736101A (en) |
CA (1) | CA2395007A1 (en) |
WO (1) | WO2001046258A2 (en) |
Families Citing this family (31)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6943235B1 (en) | 1999-04-12 | 2005-09-13 | Agensys, Inc. | Transmembrane protein expressed in prostate cancer |
EP1792989A1 (en) * | 1999-04-12 | 2007-06-06 | Agensys, Inc. | 13 Transmembrane protein expressed in prostate cancer |
US20020072101A1 (en) * | 2000-01-21 | 2002-06-13 | Gaughan Glen T. | Novel human nucleic acid molecules and polypeptides encoding cation channels |
US20020132303A1 (en) * | 2001-03-12 | 2002-09-19 | Millennium Pharmaceuticals, Inc. | 69318, a human sodium/calcium exchanger (transporter) family member and uses therefor |
DE10013296A1 (en) * | 2000-03-17 | 2001-09-20 | Boehringer Ingelheim Pharma | New nucleic acid encoding the non-selective cation channel OTRPC4, useful for treating osmolality-associated disorders, e.g. diabetes comprises the modulation of activity |
US20020019348A1 (en) * | 2000-08-02 | 2002-02-14 | Applera Corporation | Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
AU2001253804A1 (en) * | 2000-04-26 | 2001-11-07 | Pe Corporation (Ny) | Isolated human transporter proteins, nucleic acid molecules encoding the same, and uses thereof |
GB2369362A (en) * | 2000-08-11 | 2002-05-29 | Glaxo Group Ltd | Modulators of inwardly rectifying potassium channels |
US20020091238A1 (en) * | 2000-08-30 | 2002-07-11 | Curtis Rory A.J. | 54370, a novel human sulfate transporter and uses therefor |
US20030032776A1 (en) * | 2000-11-02 | 2003-02-13 | Feder John N. | Polynucleotide encoding a novel human potassium channel beta-subunit, K+Mbeta1 |
AU2001297625A1 (en) * | 2000-12-21 | 2002-09-12 | Bristol-Myers Squibb Company | Nucleic acid molecules and polypeptides for a human cation channel polypeptide |
AU2002246743A1 (en) * | 2000-12-27 | 2002-08-12 | Lexicon Genetics Incorporated | Human ion channel protein and polynucleotides encoding the same |
AU2002305921A1 (en) * | 2001-01-22 | 2002-10-08 | Millennium Pharmaceuticals, Inc. | Fbh58295fl, a novel human amino acid transporter and uses thereof |
AU2002312241A1 (en) * | 2001-06-05 | 2002-12-16 | Exelixis, Inc. | B3galts as modifiers of the p53 pathway and methods of use |
AU2002329196B2 (en) * | 2001-07-06 | 2008-08-07 | Senomyx, Inc. | Human olfactory nucleotide-gated ion channels |
EP1281719A1 (en) * | 2001-08-03 | 2003-02-05 | Millennium Pharmaceuticals, Inc. | A human cyclic nucleotide gated channel family member, referred as "9721", and uses thereof |
AU2002367997A1 (en) * | 2001-08-15 | 2003-12-19 | Centre National De La Recherche Scientifique (Cnrs) | Sut-2 and sut-3 genes, proteins and assays for inhibitors of lymphocyte adhesion |
GB0122789D0 (en) * | 2001-09-21 | 2001-11-14 | Babraham Inst | Differential gene expression in schizophrenia |
JP2003265179A (en) * | 2002-03-14 | 2003-09-24 | Japan Science & Technology Corp | Transporter for selectively transporting sulfate conjugate and its gene |
DE10215321A1 (en) * | 2002-04-02 | 2003-10-23 | Metagen Pharmaceuticals Gmbh | New nucleic acid encoding Trpp8 splice variants, useful for diagnosis of prostatic cancer, and to screen for diagnostic or therapeutic agents, also related proteins |
AU2003226797A1 (en) * | 2002-04-16 | 2003-10-27 | Bayer Healthcare Ag | Regulation of human transient receptor potential channel |
US6929923B2 (en) * | 2002-07-23 | 2005-08-16 | Rigel Pharmaceuticals, Inc. | Modulators of leukocyte activation, BIC compositions and methods of use |
AU2003257125A1 (en) * | 2002-08-02 | 2004-02-23 | Incyte Corporation | Transporters and ion channels |
CA2503346C (en) * | 2002-11-27 | 2014-03-18 | Agensys, Inc. | Nucleic acid and corresponding protein entitled 24p4c12 useful in treatment and detection of cancer |
JP2008289363A (en) * | 2005-09-05 | 2008-12-04 | National Institutes Of Natural Sciences | Protein constituting voltage-activated type proton channel and method for utilizing the same |
CN101351473A (en) * | 2005-10-31 | 2009-01-21 | 詹森药业有限公司 | A polypeptide complex of TRPM8 and calmodulin and its uses thereof |
JP2009034096A (en) * | 2008-06-12 | 2009-02-19 | J-Pharma Co Ltd | Transporter selectively transporting sulfate conjugate, and gene of the same |
JP5759664B2 (en) * | 2008-08-29 | 2015-08-05 | 花王株式会社 | CNG channel inhibitor |
JP5373346B2 (en) * | 2008-09-25 | 2013-12-18 | 独立行政法人国立循環器病研究センター | Novel transporter molecule of sphingosine 1-phosphate |
JP5733909B2 (en) * | 2010-05-12 | 2015-06-10 | 花王株式会社 | Voltage-gated cation channel inhibitor |
CN111474366A (en) * | 2020-04-02 | 2020-07-31 | 桂林医学院 | Application of Kir6.2-SUR1 as drug target for treating manganese poisoning Parkinson disease |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0834561A1 (en) * | 1996-09-27 | 1998-04-08 | Rijksuniversiteit te Leiden | A gene related to migraine in man |
-
2000
- 2000-12-20 JP JP2001547167A patent/JP2004500814A/en active Pending
- 2000-12-20 WO PCT/US2000/035095 patent/WO2001046258A2/en not_active Application Discontinuation
- 2000-12-20 EP EP00990317A patent/EP1257578A2/en not_active Withdrawn
- 2000-12-20 CA CA002395007A patent/CA2395007A1/en not_active Abandoned
- 2000-12-22 AU AU27361/01A patent/AU2736101A/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
WO2001046258A3 (en) | 2002-01-24 |
CA2395007A1 (en) | 2001-06-28 |
WO2001046258A2 (en) | 2001-06-28 |
JP2004500814A (en) | 2004-01-15 |
EP1257578A2 (en) | 2002-11-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2736101A (en) | Transporters and ion channels | |
AU2001273239A1 (en) | Transporters and ion channels | |
AU2003228869A1 (en) | Transporters and ion channels | |
AU2001280981A1 (en) | Transporters and ion channels | |
AU1225000A (en) | Combined pharmaceutical estrogen-androgen-progestin | |
AU5288800A (en) | Reliable multicast | |
AU7989400A (en) | Compounds and methods | |
AU2001271839A1 (en) | Human ion channels | |
AU3215500A (en) | Compounds and methods | |
AU6101399A (en) | Bio-assay technique | |
AU2002241569A1 (en) | Transporters and ion channels | |
AU1409100A (en) | Drugs | |
AU2001291011A1 (en) | Transporters and ion channels | |
AU2001265002A1 (en) | Transporters and ion channels | |
AU2001239860A1 (en) | Transporters and ion channels | |
AU4090299A (en) | Liposomal delivery complex | |
AU2002256215A1 (en) | Transporters and ion channels | |
AU1083501A (en) | Antibiotic-metal complex and methods | |
AU2001249906A1 (en) | Human transporters and ion channels | |
AU2003224811A1 (en) | Transporters and ion channels | |
AU3976600A (en) | Improvements in partitioning systems | |
AU1812697A (en) | Thifluzamide with improved efficacy | |
AU2002332573A1 (en) | Transporters and ion channels | |
AU1707599A (en) | Retinoid-glitazone combinations | |
AU2001273069A1 (en) | Transporters and ion channels |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |